These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24990385)

  • 21. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection.
    Zhu X; Wang LC; Chen EQ; Chen XB; Chen LY; Liu L; Lei XZ; Liu C; Tang H
    Dig Dis Sci; 2011 Sep; 56(9):2742-9. PubMed ID: 21399926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.
    Myers RP; Tainturier MH; Ratziu V; Piton A; Thibault V; Imbert-Bismut F; Messous D; Charlotte F; Di Martino V; Benhamou Y; Poynard T
    J Hepatol; 2003 Aug; 39(2):222-30. PubMed ID: 12873819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.
    Halfon P; Bourliere M; Deydier R; Botta-Fridlund D; Renou C; Tran A; Portal I; Allemand I; Bertrand JJ; Rosenthal-Allieri A; Rotily M; Sattonet C; Benderitter T; Saint Paul MC; Bonnot HP; Penaranda G; Degott C; Masseyeff MF; Ouzan D
    Am J Gastroenterol; 2006 Mar; 101(3):547-55. PubMed ID: 16542291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients.
    Kang NL; Zhang JM; Lin MX; Chen XD; Huang ZX; Zhu YY; Liu YR; Zeng DW
    World J Gastroenterol; 2020 Jul; 26(27):3952-3962. PubMed ID: 32774069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
    Tan YW; Zhou XB; Ye Y; He C; Ge GH
    World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
    Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
    J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.
    Holmberg SD; Lu M; Rupp LB; Lamerato LE; Moorman AC; Vijayadeva V; Boscarino JA; Henkle EM; Gordon SC;
    Clin Infect Dis; 2013 Jul; 57(2):240-6. PubMed ID: 23592832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B.
    Lee HJ; Seo YS; Kim DJ; Kang HS; An H; Kim JH; Cheong JY; Yim HJ; Yeon JE; Lee HS; Byun KS; Cho SW; Kim DJ; Um SH; Kim CD; Ryu HS
    J Gastroenterol Hepatol; 2011 Jun; 26(6):987-95. PubMed ID: 21198828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial.
    Poynard T; Imbert-Bismut F; Ratziu V; Chevret S; Jardel C; Moussalli J; Messous D; Degos F;
    J Viral Hepat; 2002 Mar; 9(2):128-33. PubMed ID: 11876795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients.
    Wang H; Xu H; Qu L; Wang X; Wu R; Gao X; Jin Q; Niu J
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):997-1002. PubMed ID: 27167453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B.
    Chen Y; Wang Y; Chen Y; Yu Z; Chi X; Hu KQ; Li Q; Tan L; Xiang D; Shang Q; Lei C; Chen L; Hu X; Wang J; Liu H; Lu W; Chi W; Dong Z; Wang X; Li Z; Xiao H; Chen D; Bai W; Zhang C; Xiao G; Qi X; Chen J; Zhou L; Sun H; Deng M; Qi X; Zhang Z; Qi X; Yang Y
    Clin Transl Gastroenterol; 2019 May; 10(5):1-12. PubMed ID: 31033506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.
    Vermehren J; Vermehren A; Mueller A; Carlebach A; Lutz T; Gute P; Knecht G; Sarrazin C; Friedrich-Rust M; Forestier N; Poynard T; Zeuzem S; Herrmann E; Hofmann WP
    BMC Gastroenterol; 2012 Mar; 12():27. PubMed ID: 22453133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
    Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B.
    Hu J; Zhang X; Gu J; Yang M; Zhang X; Zhao H; Li L
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):817-823. PubMed ID: 30543572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.
    Ngo Y; Munteanu M; Messous D; Charlotte F; Imbert-Bismut F; Thabut D; Lebray P; Thibault V; Benhamou Y; Moussalli J; Ratziu V; Poynard T
    Clin Chem; 2006 Oct; 52(10):1887-96. PubMed ID: 16931569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
    Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co-infected Adults.
    Sterling RK; King WC; Wahed AS; Kleiner DE; Khalili M; Sulkowski M; Chung RT; Jain MK; Lisker-Melman M; Wong DK; Ghany MG;
    Hepatology; 2020 Feb; 71(2):411-421. PubMed ID: 31220357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
    Tu XL; Xiao YQ; Chen F
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
    Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
    Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel diagnostic algorithm to predict significant liver inflammation in chronic hepatitis B virus infection patients with detectable HBV DNA and persistently normal alanine transaminase.
    Li Q; Zhou Y; Huang C; Li W; Chen L
    Sci Rep; 2018 Oct; 8(1):15449. PubMed ID: 30337643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.